MIP-1095 I-123 is a radiotracer under investigation in clinical trial NCT00712829 (Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents). References: Kelly J, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C Jr, Schlyer D, Zhao Y, Kim D, Babich JW. Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors. Eur J Nucl Med Mol Imaging. 2018 Apr 6. doi: 10.1007/s00259-018-4004-5. [Epub ahead of print] PubMed PMID: 29623376.

纯度：≥98%

CAS：949575-25-1